Drug intelligence / Profile preview

Consepsis

Development stage
Unknown
Lead developer
Ultradent Products
Modality
Small Molecules
Administration
Topical, Dental
01

Overview

Consepsis is a branded dental antimicrobial solution and cavity disinfectant formulated with 2.0% chlorhexidine gluconate. Developed and manufactured by Ultradent Products, it is primarily used in restorative dentistry to disinfect tooth preparations, such as cavities and root canals, prior to the placement of final restorations. Its mechanism of action is two-fold: it provides broad-spectrum antibacterial activity by disrupting bacterial cell membranes, which reduces the risk of secondary caries and postoperative sensitivity, and it acts as an inhibitor of host-derived matrix metalloproteinases (MMPs). By inhibiting MMPs like MMP-2 and MMP-9, Consepsis prevents the enzymatic degradation of collagen fibers within the hybrid layer of adhesive restorations, thereby enhancing the long-term durability and bond strength of resin-based materials. It is available as a liquid solution and as a slurry (Consepsis Scrub) containing pumice for surface cleaning and disinfection.

Brand names
ConsepsisConsepsis Scrub
Other names
2% chlorhexidine gluconate solutionchlorhexidine digluconate 2% solutionConcepsis
02

Targets

LPS (Lipopolysaccharide)MMP2 (Matrix metalloproteinase-2)MMP9 (Matrix metalloproteinase-9)

Beyond the preview

Go deeper on Consepsis.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Consepsis.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call